KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
KYTH was delisted on the 30th of September, 2015.
102 hedge funds and large institutions have $704M invested in KYTHERA BIOPHARMACEUTICALS, INC COM in 2014 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 45 increasing their positions, 28 reducing their positions, and 14 closing their positions.
71% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 14
61% more repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 28
20% more capital invested
Capital invested by funds: $589M → $704M (+$116M)
11% more funds holding
Funds holding: 92 → 102 (+10)
10% more call options, than puts
Call options by funds: $800K | Put options by funds: $724K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$46M |
| 2 |
PCM
Pentwater Capital Management
Naples,
Florida
|
+$17.4M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$10.4M |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$7.68M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$6.26M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$12.3M |
| 2 |
Millennium Management
New York
|
-$9.61M |
| 3 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
-$8.91M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$6.07M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
-$5.12M |
KYTH Hedge Fund Activity: Q1 2014 in Review
102 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) for Q1 2014, worth a combined $704M — up 20% from $589M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new KYTH positions and 14 closed out — a net gain of 10 holders — while 45 added to existing stakes and 28 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $46M. The largest seller was Adage Capital Partners, cutting an estimated $12.3M.
- 102 institutional investors held KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) as of Q1 2014, up from 92 in Q4 2013.
- Funds reported $704M of KYTHERA BIOPHARMACEUTICALS, INC COM stock for Q1 2014, up 20% quarter-over-quarter.
- 24 funds opened new KYTHERA BIOPHARMACEUTICALS, INC COM positions in Q1 2014 and 14 closed out, a net change of +10 holders.
- The largest KYTHERA BIOPHARMACEUTICALS, INC COM buyer in Q1 2014 was Fidelity Investments, an estimated $46M added.
- The largest KYTHERA BIOPHARMACEUTICALS, INC COM seller in Q1 2014 was Adage Capital Partners, an estimated $12.3M sold.
Based on aggregated 13F filings for Q1 2014.